Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelin (Msln)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07030907
What this trial is testing

Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer
Outpace Bio, Inc. 30
Early research (Phase 1)UnknownNCT03747965
What this trial is testing

Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors

Who this might be right for
Solid Tumor, Adult
Chinese PLA General Hospital 10
Early research (Phase 1)Ended earlyNCT03436732
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT03030001
What this trial is testing

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

Who this might be right for
Solid Tumor, AdultAdvanced Cancer
Ningbo Cancer Hospital 40
Early research (Phase 1)Study completedNCT03507452
What this trial is testing

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Who this might be right for
Advanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more
Bayer 36
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT01950572
What this trial is testing

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Who this might be right for
ThymomaStomach NeoplasmsPancreatic Neoplasms+3 more
National Cancer Institute (NCI) 1,000
Not applicableUnknownNCT03638193
What this trial is testing

Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shenzhen BinDeBio Ltd. 10
Early research (Phase 1)UnknownNCT05775666
What this trial is testing

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
Peking University 87
Early research (Phase 1)UnknownNCT02930993
What this trial is testing

Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors

Who this might be right for
Mesothelin Positive Tumors
China Meitan General Hospital 20
Early research (Phase 1)Looking for participantsNCT06623396
What this trial is testing

Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Who this might be right for
Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more
Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT05848999
What this trial is testing

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang University 87
Not applicableStudy completedNCT01393483
What this trial is testing

Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)

Who this might be right for
Esophageal CancerAdenocarcinoma
Memorial Sloan Kettering Cancer Center 371
Early research (Phase 1)Study completedNCT02884726
What this trial is testing

Phase 1 Study of Mesothelin-ADC

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 8
Very early researchUnknownNCT03692637
What this trial is testing

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Allife Medical Science and Technology Co., Ltd. 30
Early research (Phase 1)Study completedNCT01439152
What this trial is testing

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Who this might be right for
Oncology
Bayer 148
Very early researchUnknownNCT03497819
What this trial is testing

Autologous CARTmeso/19 Against Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University 10
Early research (Phase 1)Looking for participantsNCT05403554
What this trial is testing

NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Who this might be right for
Epithelial Ovarian CancerTriple Negative Breast CancerNon-squamous Non-small-cell Lung Cancer+2 more
Light Chain Bioscience - Novimmune SA 70
Very early researchLooking for participantsNCT06249256
What this trial is testing

An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells

Who this might be right for
Solid Tumor
Shanghai Cell Therapy Group Co.,Ltd 12
Next Page